Edesabiotech
NASDAQ: EDSA1 known investors
Edesa Biotech is a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics to treat inflammatory and immune-related diseases, with a current focus on acute respiratory distress syndrome and other immune dysregulation conditions.